The JV is owned 55 % Mitsubishi Gas Chemical and 45 % by Nippon Kayaku. The manufacturing facility will provide 1000 and 2000 L scale culture vessels for the production of biosimilars from reombinant animal cells or microorganisms.
Mitsubishi Gas Chemical news release, June 8, 2016
Mitsubishi Gas Chemical and Nippon Kayaku form Cultivecs Inc., a JV for manufacturing of biopharmaceuticals